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The natural course of psoriasis is often modulated
during pregnancy, indicating the regulatory e¡ect of
estrogen or progesterone on psoriasis. Interferon-
induced protein of 10 kDa chemoattracts T helper 1
cells, and interferon-induced protein of 10 kDa produc-
tion by keratinocytes is enhanced in psoriatic skin
lesions. We examined in vitro e¡ects of sex hormones
on the interferon-induced protein of 10 kDa production
by human keratinocytes. 17b-estradiol inhibited inter-
feron-c-induced interferon-induced protein of 10 kDa
secretion, mRNA expression, and promoter activity.
Interferon-stimulated response element on the promo-
ter was responsible for the inhibition by 17b-estradiol.
Interferon-c-induced protein of 10 kDa production
was also inhibited by anti-estrogens, ICI 182 780 and
tamoxifen, and membrane-impermeable bovine serum
albumin-conjugated 17b-estradiol, suggesting the e¡ects
via membrane estrogen receptor, whereas 17a-estradiol,
progesterone, and dihydrotestosterone had no e¡ects.
17b-estradiol and bovine serum albumin-conjugated
17b-estradiol suppressed interferon-c-induced tran-
scription through the interferon-stimulated response
element and signal transducer and activator of tran-
scription 1a binding to interferon-stimulated response
element. 17b-estradiol and bovine serum albumin-
conjugated 17b-estradiol suppressed interferon-c-in-
duced tyrosine phosphorylation of signal transducer
and activator of transcription 1a, and Janus tyrosine
kinase 1 and 2. 17b-estradiol-mediated suppression on
the interferon-c-induced signal transducer and activator
of transcription 1a activation and interferon-induced
protein of 10 kDa synthesis was counteracted by adeny-
late cyclase inhibitor SQ22536. 17b-estradiol, bovine
serum albumin-conjugated 17b-estradiol, ICI 182 780,
and tamoxifen increased intracellular 30,50 -adenosine
cyclic monophosphate level by activating adenylate
cyclase in keratinocytes. Fluorescein isothiocyanate-
labeled bovine serum albumin-conjugated 17b-estradiol
bound to the surface of keratinocytes, and mRNA
for estrogen receptor b but not for estrogen receptor a
was detected in keratinocytes. These results suggest
that 17b-estradiol may interact with the membrane
receptor on keratinocytes and generate 30,50 -adenosine
cyclic monophosphate by activating adenylate cyclase,
which may lead to the inhibition of interferon-c-
induced signal transducer and activator of transcription
1a activation and interferon-induced protein of 10 kDa
synthesis. Key words: 30,50 -adenosine cyclic monophosphate/
psoriasis/signal transducer and activator of transcription 1a.
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P
soriasis is characterized by epidermal hyperplasia
associated with vascular proliferation and in£ammatory
in¢ltrates (Bos and de Rie, 1999). The lymphocytes
in¢ltrating into psoriatic lesions are predominantly
activated T helper 1 cells (Bos and de Rie, 1999), indi-
cating the involvement of chemokines selectively attracting acti-
vated T helper 1 cells. Interferon-induced protein of 10 kDa (IP-
10) is a member of the CXC chemokine family and preferentially
attracts activated T helper 1 cells through the cell surface CXC
chemokine receptor 3 (Kaplan, 2001). Keratinocytes can produce
IP-10 in response to interferon (IFN)-g (Boorsma et al, 1998), and
the expression of IP-10 is enhanced in keratinocytes of psoriatic
skin lesion (Rottman et al, 2001). T helper 1 cells in¢ltrating into
psoriatic skin lesion may produce IFN-g, which induces IP-10
production by keratinocytes, and the produced IP-10 in turn at-
tracts activated T helper 1 cells into the lesional skin. Such a posi-
tive feedback loop of IFN-g/IP-10 may sustain the T helper
1-mediated in£ammation in psoriasis.
It is known that natural course of psoriasis is in£uenced by
pregnancy; 30^40% of pregnant women with psoriasis noticed
improvement, 20% reported deterioration, and the remaining
40^50% had no change (Farber and Nall, 1974; Dunna and Finlay,
1989; Boyd et al, 1996; Mowad et al, 1998). On the other hand,
some pustular forms of psoriasis often occur or exacerbate
during pregnancy (Breier-Maly et al, 1999). It is also reported that
48% of women with psoriasis noted exacerbation at menopause
(Mowad et al, 1998) and the peak in the onset age at about 50 y
can only be seen for women, and coincides with menopause
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(Swanbeck et al, 1994). These indicate that the course of psoriasis
may be in£uenced by female hormones such as estrogen whose
levels increase during pregnancy and decrease at menopause. It is
reported that increased concentrations of estrogen enhance the
production of anti-in£ammatory cytokine, interleukin-10 while
decreasing the production of proin£ammatory cytokine, tumor
necrosis factor-a in CD4þ T cell clones from multiple sclerosis
patients (Correale et al, 1998). Matejuk et al (2001) also reported
that estrogen treatment in vivo inhibited IP-10 production in mice
with experimental autoimmune encephalomyelitis; however, the
precise mechanism for this e¡ect is unknown.
It is known that steroid hormones manifest their e¡ects by two
di¡erent mechanisms: genomic e¡ects and nongenomic e¡ects.
The former is that the classical nuclear receptor binds to the re-
spective hormone and this hormone-receptor complex upregu-
lates or downregulates the transcription of various genes by
binding to hormone response element of the genes or by interact-
ing with other transcription factors, such as activator protein-1
(Beato, 1989; Paech et al, 1997). On the other hand, in the latter
case, steroid hormones rapidly upregulate or downregulate a vari-
ety of intracellular signals; estrogen activates adenylate cyclase
(AC) (Aronica et al, 1994), phospholipase C (Razandi et al, 1999),
or extracellular signal-regulated kinase (ERK) (Migliaccio et al,
1996), or induces Ca2þ signal (Benten et al, 1998). The recent stu-
dies reported the presence of membrane steroid receptors, which
mediate rapid nongenomic steroid actions (Papas et al, 1995). As
above-mentioned signaling molecules are involved in the expres-
sion of certain genes, the nongenomic signal-modulating e¡ects
of sex hormones may also lead to the upregulation or downregu-
lation of certain gene expression. In this study, we examined the
in vitro e¡ects of sex hormones on IFN-g-induced IP-10 produc-
tion by human keratinocytes. We found that 17b-estradiol (E2)
inhibited the IP-10 production and the e¡ects may be mediated
via cell surface receptors.
MATERIALS AND METHODS
Reagents 17b-estradiol 6-(O-carboxymethyl)oxime:bovine serum
albumin (E2-BSA), £uorescein isothiocyanate-conjugated E2-BSA (E2-
BSA-FITC), 17a-estradiol, tamoxifen, progesterone, dihydrotestosterone
(DHT), and testosterone were purchased from Sigma (St Louis, MO). ICI
182 780 was fromWako Pure Chemical Industries (Osaka, Japan). U73122,
PD98059, and SQ22536 were obtained from Calbiochem (La Jolla, CA).
Recombinant human IFN-g was purchased from R&D (Minneapolis,
MN). Antibodies used in the electrophoretic mobility shift assay (EMSA),
immunoprecipitation, and immunoblotting were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA).
Culture of normal human epidermal keratinocytes Human
neonatal foreskin keratinocytes were cultured in serum-free keratinocyte
growth medium (Clonetics, Walkersville, MD) consisting of basal
medium MCDB153 supplemented with 0.5 mg hydrocortisone per ml, 5
ng epidermal growth factor per ml, 5 mg insulin per ml, and 0.5% bovine
pituitary extract. The cells in third passage were used for the experiments.
Measurement of IP-10 secretion Keratinocytes (2104 per well) were
seeded in triplicate into 24-well plates in 1 ml keratinocyte growth
medium, adhered overnight, then the medium was changed to basal
keratinocyte basal medium (KBM) depleted of phenol red, hormones,
growth factors, and bovine pituitary extract, and incubated for 24 h. At
about 60% con£uency, the medium was removed and the cells were
preincubated with sex hormones for 10 min, then incubated with IFN-g
in the presence of hormones for another 24 h. The supernatants were
assayed for IP-10 by enzyme-linked immunosorbent assay (HyCult
Biotechnology, b.v. Uden, the Netherlands). The sensitivity of the assay
was 20 pg per ml.
Reverse transcription^polymerase chain reaction (reverse
transcription^PCR) Keratinocytes were incubated as above for 3 h,
and RNA was extracted using mRNA puri¢cation kit (Pharmacia,
Uppsala, Sweden) according to the manufacturer’s instructions. cDNA
was made from RNA samples as described (Tjandrawinata et al, 1997).
Primers for ampli¢cation were as described (Boorsma et al, 1998; Takano
et al, 2002). PCR was performed by one denaturing cycle of 951C for
3 min, 30 cycles of denaturation at 951C for 30 s, annealing at 581C
for 30 s, and extension at 721C for 30 s, and a ¢nal extension at 721C for
3 min. In preliminary experiments, 30 cycles was shown to lie in the linear
portion of the curve for the amount of PCR product for the housekeeping
gene, glyceraldehyde-3-phosphate dehydrogenase. The PCR products were
analyzed by electrophoresis on 2.5% agarose gels and stained with
ethidium bromide, viewed by ultraviolet light, and photographed.
Densitometric analysis was performed by scanning the bands into
Photoshop and performing densitometry with NIH Image Software.
Plasmids and transfections The ¢re£y luciferase reporter plasmids
driven by human IP-10 promoter (525/þ 97 bp relative to the
transcriptional start site) were constructed by PCR and insertion into
pGL3 basic vector (Promega, Madison,WI) as described (Majumder et al,
1998). Site-speci¢c mutation in IFN-stimulated response element (ISRE)
and two nuclear factor (NF)-kB binding sites of the human IP-10
promoter were created by multiple rounds of PCR using appropriate
primers with altered bases as described (Ohmori and Hamilton, 1993).
p3xISRE-SV-luc was constructed by inserting three copies of ISRE
(50 -CGCTTTGGAAAGTGAAACCTACCTC-30, consensus sequence
underlined) from human IP-10 promoter in front of heterologous
minimal SV40 promoter upstream of ¢re£y luciferase reporter as
described (Ohmori and Hamilton, 1993; Ohmori et al, 1994). Transient
transfections were performed with E¡ectene (Qiagen, Tokyo, Japan) as
described (Zellmer et al, 2001). Keratinocytes were plated in six-well plates
and grown to about 60% con£uence. Twenty-four hours before the
transfection, the medium was changed to phenol red-free KBM.
Keratinocytes in KBM were incubated for 6 h with 0.4 mg of luciferase
construct and 0.1 mg of Rous sarcoma virus b-galactosidase vector
premixed with enhancer, transfection bu¡er, and E¡ectene. The cells were
washed and incubated in KBM for 18 h, then treated with sex hormones in
the presence or absence of IFN-g at indicated concentrations for 6 h. Cell
extracts were prepared and luciferase activities were quanti¢ed using a
luciferase assay system (Promega). The same cell extracts were assayed for
b-galactosidase activity using chemiluminescent Galacto-Light kit (Tropix,
Bedford, MA). All readings were taken using a Lumat 9501 luminometer
(Berthold,Wildbach, Germany). The results obtained in each transfection
were normalized for b-galactosidase activity and expressed as relative
luciferase activity. In preliminary experiments, less than 104 M of E2 did
not alter Rous sarcoma virus promoter activity in transfected keratinocytes
as determined by b-galactosidase activity normalized for protein amount
of the cell lysates.
EMSA The probe used was annealed double-stranded DNA containing
ISRE from the human IP-10 promoter. The probe was labeled by
incorporation of [32P]deoxycytidine triphosphate with Klenow DNA
polymerase. For gel shift assays, 2^5 mg of nuclear protein extracts were
incubated at room temperature for 5 min with a mixture containing 6
mM HEPES (pH 7.9), 0.4 mM ethylenediamine tetraacetic acid, 125 mM
KCl, 10% glycerol, 0.05 mg poly(dI-dC) per ml, 1 mM dithiothreitol, 2.5
mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 10
mM NaF, 50 mg aprotinin per ml, and 50 mg leupeptin per ml.
Approximately, 1 ng labeled probe was added and the reactions
were incubated at room temperature for another 20 min. In antibody
supershift experiments, the nuclear extracts were preincubated with
various antibodies on ice for 30 min before the addition of probe.
Reactions were then fractionated on a nondenaturing 5% polyacrylamide
gel in 0.5Tris borate with EDTA. The gels were dried and visualized
with PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Analysis of signal transducer and activator of transcription
(STAT)1a and Janus tyrosine kinase (Jak)1/2 phosphorylation The
phosphorylation status of Jak1/Jak2 and STAT1a was assessed by
immunoprecipitation followed by immunoblotting as described (Delgado
and Ganea, 2000). Cells were lyzed in ice-cold immunoprecipitation bu¡er
(50 mM Tris, pH 7.4, 150 mM NaCl, 1mM ethylenediamine tetraacetic acid, 1
mM Na3VO4, 20 mM b-glycerol phosphate, 1 mM phenylmethylsulfonyl
£uoride, 1 mg leupeptin per ml, 2 mg aprotinin per ml, 1 mg pepstatin per
ml, 1% Nonidet P-40, 0.25% deoxycholate, and 0.1% sodium dodecyl
sulfate). STAT1a and Jak1/Jak2 molecules were immunoprecipitated by
incubation with 10 mg per ml of respective antibodies. The immune
complexes were captured on protein G-Sepharose beads (Pharmacia,
Piscataway, NJ) for 1 h at 41C. Precipitated proteins were washed
by immunoprecipitation bu¡er and were separated by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis and transferred to a
nitrocellulose membrane. The membrane was blocked and incubated with
1 mg per ml of anti-phosphotyrosine antibody (PY20), then incubated with
horseradish peroxidase-conjugated goat anti-mouse IgG, and developed.
Following the analysis of phosphorylated molecules, the blots were
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stripped and reprobed with antibodies against respective proteins as
described above.
Measurement of cyclic 30,50 -monophosphate (cAMP) amount
Keratinocytes were plated at 2104 cells per well in 24-well plates,
adhered overnight, washed, and incubated with phenol red-free KBM for
24 h. The cells were then incubated with indicated concentrations of sex
hormones in 1 ml per well of phenol red-free KBM for the indicated
duration. The medium was discarded, and the cells were lyzed with
acetate bu¡er (pH 5.8) containing 0.25% dodecyltrimethylammonium
bromide. The cAMP amount in the lysate was measured by enzyme-
linked immunosorbent assay (Amersham, Arlington Heights, IL)
according to the manufacturer’s instruction. The sensitivity of the assay
was 12 fmol per assay well. The intracellular cAMP level was presented as
pmol/106 cells.
Measurement of AC activity Keratinocytes were cultured with sex
hormones for 5 min in 24-well plates as described above, and were
homogenized in the bu¡er containing 75 mM Tris^HCl (pH 7.4), 2 mM
ethylenediamine tetraacetic acid, 8 mM MgCl2 and centrifuged at 1000 g
for 5 min and 40,000 g for 20 min. The pellet was used as a membrane
fraction for AC assays as described (Salomon et al, 1974; Choi et al, 1992)
using 1 mM [a-32P]adenosine triphosphate (30 Ci per mmol) (Amersham)
as a substrate.
Measurement of cyclic nucleotide phosphodiesterase activity
Keratinocytes were homogenized as above, then sonicated on ice, and
centrifuged at 30,000 g for 15 min cyclic nucleotide phosphodiesterase
activity of the supernatants was assayed as described (Epstein et al, 1980;
Robicsek et al, 1991) using 1 mM [2,8^3H]cAMP (30 Ci per mmol)
(Amersham) as a substrate.
Flow cytometry Subcon£uent keratinocytes were harvested and
labeled with E2-BSA-FITC 15 mM for 1 h at room temperature. BSA-
FITC was used as controls. Cells were analyzed in a FACScan (Becton
Dickinson, Sunnyvale, CA) with a sample size of 10,000 cells gated, and
the data were processed using the FACScan software as described (Benten
et al, 1991).
RESULTS
The e¡ects of sex hormones on IP-10 secretion in
keratinocytes The constitutive IP-10 secretion with medium
alone was minimal in keratinocytes (mean7SEM 8179 pg per
ml, n¼ 5), and IFN-g 10 ng per ml enhanced the IP-10 secretion
up to 15107142 pg per ml (n¼ 5). Though E2 did not alter the
constitutive IP-10 secretion, it suppressed IFN-g-induced IP-10
secretion (Fig 1a); the signi¢cant e¡ect of E2 occurred at 1010
M, and increased in a concentration-dependent manner and
maximized at 108 M, which inhibited the IFN-g-induced IP-10
secretion by 71%. In contrast, progesterone, DHT (Fig 1a), or
testosterone (data not shown) neither altered constitutive nor the
IFN-g-induced IP-10 secretion. E2 stereoisomer 17a-estradiol did
not alter the IFN-g-induced IP-10 secretion (Fig 1b). Membrane-
impermeable E2-BSA inhibited the IFN-g-induced IP-10
secretion (Fig 1b), indicating that the e¡ect of E2 may be
exerted on the membrane surface, and not via intracellular
estrogen receptor (ER). Bovine serum albumin alone did not
a¡ect the IFN-g-induced IP-10 secretion. Anti-estrogens, ICI 182
780 and tamoxifen did not counteract the e¡ects of E2 but
inhibited the IFN-g-induced IP-10 secretion in the absence of
E2 (Fig 1b). Similar results were obtained in keratinocytes
stimulated with 100 ng IFN-g per ml (data not shown). Thus E2
inhibited IFN-g-induced IP-10 secretion, and the e¡ect appeared
to occur at the membrane surface.We then examined if E2 may
inhibit IP-10 mRNA expression induced by IFN-g.
The e¡ects of E2 on IFN-c-induced IP-10 mRNA
expression Though E2 alone did not alter IP-10 mRNA level
in unstimulated keratinocytes, E2 suppressed the IFN-g-induced
IP-10 mRNA expression by 67% of controls (Fig 2). E2-BSA,
ICI 182 780, and tamoxifen inhibited IFN-g-induced IP-10
mRNA expression as well as E2, whereas progesterone, DHT
(Fig 2), and testosterone (data not shown) were not inhibitory.
Thus E2 inhibited IFN-g-induced IP-10 production at
pretranslational level.We then examined if E2 may suppress IP-
10 promoter activity induced by IFN-g.
The e¡ects of E2 on IP-10 promoter activity We transiently
transfected human IP-10 promoter-luciferase reporter constructs
into keratinocytes, and the promoter activity was assessed by the
relative luciferase activities of the cell lysates. IFN-g 10 ng per ml
increased wild-type IP-10 promoter activity 9.3-fold of controls
(Fig 3b, uppermost four columns), and E2 suppressed the
response to IFN-g by 71%. Membrane-impermeable E2-BSA
(Fig 3b) and ICI 182 780 and tamoxifen (data not shown)
suppressed the IFN-g-induced IP-10 promoter activation as well
as E2, whereas progesterone, DHT, or testosterone were not
inhibitory (data not shown).
IP-10 promoter contains two NF-kB sites and the element
corresponding to ISRE (Ohmori and Hamilton, 1993; Ohmori
et al, 1997; Majumder et al, 1998) (Fig 3a). We thus examined
which of these elements may be responsible for the inhibition
by E2 on the IFN-g-induced IP-10 transcription. The mutation
of ISRE completely abrogated the induction by IFN-g of IP-10
promoter and the suppression by E2 or E2-BSA on the response
to IFN-g (Fig 3b, the second four columns), suggesting that
ISRE is necessary for IFN-g-induced promoter activation and
may be involved in the suppression by E2 on the response to
IFN-g. When either NF-kB2 (distal NF-kB site) or NF-kB1
Figure1. Dose dependency for the e¡ects of sex hormones on IFN-
c-induced IP-10 secretion in human keratinocytes (a) and the hor-
mone speci¢city in the inhibition on the secretion (b). (a) Human
keratinocytes were preincubated with indicated concentrations of sex hor-
mones for 10 min, then incubated with 10 ng IFN-g per ml. After 24 h, the
culture supernatants were assayed for IP-10 secretion.Values are mean7SD
of triplicate cultures. npo0.05 vs control cultures without hormones, by
one-way analysis of variance (ANOVA) with Dunnett’s multiple comparison
test. The data shown in the ¢gure are representative of ¢ve separate experi-
ments. (b) Keratinocytes were preincubated for 10 min with 108 M E2, 106
M ICI 182 780 (ICI), 106 M tamoxifen (TAM), 107 M E2-BSA, 108 M
BSA, or 108 M 17a-estradiol (17a-E2) alone or in combination, then incu-
bated with 10 ng IFN-g per ml for another 24 h. Values are mean7SEM
(n¼ 5). npo0.05 vs control cultures with medium alone, wpo0.05 vs cul-
tures with IFN-g alone, by one-way ANOVAwith Sche¡e’s multiple compar-
ison test.
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(proximal NF-kB site) was mutated, the basal promoter activity
was reduced, whereas the fold-induction by IFN-g and the
suppression by E2 or E2-BSA on the response to IFN-g were
retained. Thus the two NF-kB sites may not be involved in the
suppression by E2 on the response to IFN-g. The results were
similar when ICI 182 780 or tamoxifen was used in place of E2
(data not shown). We then analyzed if E2 may suppress the
ISRE-dependent transcription induced by IFN-g.
The e¡ects of E2 on the IFN-c-induced transcription from
ISRE Keratinocytes were transiently transfected with plasmid
containing three repeats of ISRE linked to the heterologous
minimal SV40 promoter and luciferase reporter, and were
incubated with E2 together with IFN-g. IFN-g increased the
ISRE-dependent transcriptional activity, and E2 or E2-BSA
suppressed the response to IFN-g by 74% or 73% of controls,
respectively (Fig 4, the upper four columns). ICI 182 780 and
tamoxifen inhibited the IFN-g-induced transcription through
ISRE in a manner similar to E2 whereas progesterone, DHT,
and testosterone were not inhibitory (data not shown).We then
examined if E2 may suppress the IFN-g-induced transcription
factor binding to ISRE.
The e¡ects of E2 on transcription factor binding to
ISRE The nuclear extracts from unstimulated keratinocytes
did not form a DNA^protein complex with an ISRE probe
(Fig 5, lane 2). IFN-g induced a DNA^protein complex with
ISRE (Fig 5, lane 3), and the antibodies against STAT1a and 48
kDa ISRE-binding protein (p48) supershifted the IFN-g-
induced complex (Fig 5, lanes 7 and 8), indicating the presence of
STAT1a and p48 in the complex. The addition of E2 or E2-BSA
reduced the amount of the IFN-g-induced complex with the
ISRE probe (Fig 5, lanes 4 and 6). This suggests that E2 may
suppress IFN-g-induced STAT1a/p48 binding to ISRE in
keratinocytes. Antibody against IFN regulatory factor-2, a
transcriptional repressor, did not supershift the complex by E2
plus IFN-g-incubated cells (Fig 5, lane 5). This indicates that IFN
Figure 2. The e¡ects of sex hormones on IFN-c-induced IP-10
mRNA expression in human keratinocytes. Keratinocytes were prein-
cubated with 108 M, E2, 107 M E2-BSA, 106 M ICI 182 780 (ICI), 106 M
tamoxifen (TAM), 106 M progesterone (PRO), or 106 M DHT for 10 min,
then incubated with IFN-g 10 ng per ml for another 3 h. RNAwas iso-
lated, and reverse transcription^PCRwas performed. The intensity of the
band for IP-10 was corrected to that for glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH). The lower graph shows the corrected intensities rela-
tive to that in control cells cultured with medium alone (set as 1.0). The
results shown in the ¢gure are representative of ¢ve separate experiments.
Figure 3.The e¡ects of E2 on IFN-c-induced activities of wild-type
or mutated IP-10 promoters in human keratinocytes. (a) Schematic
representation of human IP-10 promoter. The locations of ISRE, NF-
kB2, and NF-kB1 are shown with their sequences, and substituted or de-
leted bases for mutation are indicated. The nucleotide positions are relative
to the transcriptional start site. (b) Keratinocytes were transiently trans-
fected with wild-type (WT) or mutated human IP-10 promoter linked to
luciferase reporter together with b-galactosidase vector, and preincubated
with 108 M E2 or 107 M E2-BSA for 10 min, then incubated with IFN-
g 10 ng per ml for 6 h. Relative luciferase activities normalized to b-galac-
tosidase activities were shown. The data are mean7SEM (n¼ 4).Values at
right indicate the fold induction vs basal promoter activity. npo0.05 vs con-
trol values and wpo0.05 vs values with IFN-g alone, by one-way ANOVA
with Sche¡e’s multiple comparison test.
Figure 4.The e¡ect of E2 on IFN-c-induced activation of transcrip-
tion through ISRE. Keratinocytes were transiently transfected with luci-
ferase reporter plasmids driven by ISRE linked to heterologous SV-40
minimal promoter together with b-galactosidase vector. The cells were
preincubated with 108 M E2 or 107 M E2-BSA, then incubated with
IFN-g 10 ng per ml for 6 h. The results are shown as relative luciferase
activities normalized for b-galactosidase activities, and represent
mean7SEM (n¼ 4). Values at right indicate the fold induction vs basal
activity. npo0.05 vs control values with medium alone and wpo0.05 vs
values with IFN-g alone, by one-way ANOVA with Sche¡e’s multiple
comparison test.
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regulatory factor-2 may not be present in the complex and thus
may not be involved in E2-induced inhibition of STAT1a/p48
binding to ISRE. ICI 182 780 and tamoxifen also reduced the
amount of the IFN-g-induced complex with the ISRE probe,
whereas progesterone, DHT, and testosterone were not
inhibitory (data not shown).
The e¡ects of E2 on IFN-c-induced tyrosine phospho-
rylation of STAT1a, Jak1, and Jak2 Upon IFN-g binding,
cell surface IFN-g receptor dimerizes, which allow the receptor-
associated Jak1 and Jak2 to autophosphorylate on tyrosine. The
activated Jak1 and Jak2 tyrosine-phosphorylate the intracellular
domains of IFN-g receptors, which induces the recruitment of
STAT1a to the receptors. The receptor-associated STAT1a is then
tyrosine-phosphorylated by the activated Jak1 and Jak2 (Delgado
and Ganea, 2000), which induces STAT1a dimerization and
association with p48. The activated STAT1a homodimers/p48
complex translocates to the nucleus and binds to ISRE on the
IP-10 gene (Bluyssen et al, 1995). Thus the suppression by E2 on
IFN-g-induced STAT1a activation indicates that E2 may suppress
the IFN-g-induced tyrosine phosphorylation of STAT1a, Jak1, or
Jak2. We examined the e¡ects of E2 on the tyrosine
phosphorylation status of these molecules. IFN-g induced
tyrosine phosphorylation of STAT1a, Jak1, and Jak2 in
keratinocytes (Fig 6, the upper panel, lane 2), and that was supp-
ressed by E2 or E2-BSA (Fig 6, the upper panel, lanes 3 and 4).
The total amount of STAT1a, Jak1, or Jak2 in the immuno-
precipitates was not altered by IFN-g, E2, or E2-BSA (Fig 6, the
lower panel). ICI 182 780 and tamoxifen also inhibited the IFN-g-
induced tyrosine phosphorylation of STAT1a, Jak1, and Jak2,
whereas progesterone, DHT, or testosterone had no e¡ects (data
not shown).
The E2-induced signaling pathway responsible for the
inhibition of IFN-c-induced STAT1a activation and IP-10
production E2 binding to cell surface activates a variety of
signal-transducing enzymes; AC, phospholipase C, or ERK
(Razandi et al, 1999; Wade et al, 2001). We thus aimed to de¢ne
the E2-mediated signaling enzyme responsible for the inhibition
on IFN-g-induced STAT1a activation and IP-10 synthesis.
SQ22536, the inhibitor of AC, which catalyzes cAMP genera-
tion, counteracted the suppression by E2 on IFN-g-induced
IP-10 secretion (Fig 7a), mRNA expression (Fig 7c), and
promoter activation (Fig 7b) in keratinocytes, whereas these
were not counteracted by phospholipase C inhibitor U73122,
ERK kinase (MEK1) inhibitor PD98059. The inhibition by E2-
BSA, ICI 182 780, or tamoxifen on IFN-g-induced IP-10
production was similarly counteracted by SQ22536 but not by
U73122 or PD98059 (data not shown). These suggest that AC
activation and resultant cAMP signal may be responsible for the
suppression by E2 on IFN-g-induced IP-10 synthesis. This is
supported by the fact that cell-permeable cAMP analog
dibutyryl cAMP inhibited IFN-g-induced IP-10 synthesis as
well as E2 (Fig 7).We then analyzed if cAMP signal may also be
involved in the E2-induced suppression of STAT1a activation.
SQ22536 counteracted the suppression by E2 on ISRE-
dependent transcription induced by IFN-g in keratinocytes,
whereas that was not counteracted by U73122 or PD98059 (Fig
8a). SQ22536 did counteract (Fig 8b,c, lane 4) but U73122 and
PD98059 did not counteract (Fig 8b,c, lanes 5 and 6) the
suppression by E2 on transcription factor binding to ISRE
(Fig 8b) and on tyrosine phosphorylation of STAT1a, Jak1, and
Jak2 (Fig 8c, the upper panel) induced by IFN-g. SQ22536 did
counteract but U73122 and PD98059 did not counteract the
suppression by E2-BSA, ICI 182 780, or tamoxifen on IFN-g-
induced transcription factor binding to ISRE and on tyrosine
phosphorylation of STAT1a, Jak1, and Jak2 (data not shown).
These results suggest that cAMP signal may be responsible for
the inhibition by E2 on IFN-g-induced STAT1a activation. This
is also supported by the fact that dibutyryl cAMP inhibited IFN-
g-induced STAT1a activation as well as E2 (Fig 8).
E2-induced cAMP signal We then examined if E2 may
generate cAMP signal in keratinocytes. E2 rapidly (within 5
min) increased intracellular cAMP concentration up to 5-fold of
basal level, which was followed by gradual decrease and recovery
to the basal level at 3 h (Fig 9). IFN-g did not alter cAMP level in
the presence or absence of E2. E2-BSA, ICI 182 780, and
tamoxifen increased cAMP level similarly to E2, whereas
progesterone, DHT (Fig 9), and testosterone (data not shown)
had no e¡ects. The cAMP increases by E2, E2-BSA, ICI 182 780,
and tamoxifen were associated with increased activities of cAMP-
generating AC with no signi¢cant change in the activities of
cAMP-hydrolyzing cyclic nucleotide phosphodiesterase (data not
shown). These results suggest that E2 may activate AC and
generate cAMP in keratinocytes.
E2 binding sites on the cell surface of keratinocytes As
impermeable E2-BSA-generated cAMP as well as E2, E2 may
act on cell surface of keratinocytes. To test the presence of
membrane estrogen-binding sites, we analyzed the binding of
E2-BSA-FITC to keratinocytes. FACScan analysis showed that
Figure 5. The e¡ect of E2 on IFN-c-induced transcription factor
binding to ISRE. Keratinocytes were preincubated with 108 M E2 or
107 M E2-BSA, then incubated with 10 ng IFN-g per ml for 30 min, and
nuclear extracts were prepared. The nuclear extracts were incubated with
32P-labeled oligonucleotides containing ISRE from human IP-10 promo-
ter. In supershift assays, antibodies against transcription factors were incu-
bated for 30 min before the addition of the probe. Arrows indicate the
supershifted complexes. The results shown in the ¢gure are representative
of four separate experiments. IRF-2, IFN-regulatory factor-2.
Figure 6. The e¡ects of E2 on STAT1a (a), Jak1 (b), or Jak2 (c) tyro-
sine phosphorylation induced by IFN-c. Keratinocytes were preincu-
bated with 108 M E2 or 107 M E2-BSA for 10 min prior to the addition
of IFN-g 10 ng per ml. After 10 min, cell lysates were immunoprecipitated
with anti-STAT1a, Jak1, or Jak2 antibodies followed by immunoblotting
with anti-phosphotyrosine antibody (upper panel). The blots were also
stripped and reprobed with anti-STAT1a, Jak1, or Jak2 antibodies, respec-
tively (lower panel). The results shown in the ¢gure are representative of ¢ve
separate experiments.
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the binding of E2-BSA-FITC occurred on 65% of keratinocytes
(Fig 10a). This binding was speci¢c to E2, as BSA-FITC without
conjugated E2 did not adhere to keratinocytes.We then analyzed
which ER genes were expressed in keratinocytes. Reverse
transcription^PCR detected the ERb mRNA but not that of
ERa in keratinocytes (Fig 10b).
DISCUSSION
This study demonstrated that E2 inhibited IFN-g-induced IP-10
production in human neonatal foreskin keratinocytes. We also
preliminarily found that E2 similarly inhibited IFN-g-induced
IP-10 secretion and mRNA expression in keratinocytes from le-
sional skin of psoriasis (data not shown). E2 may activate AC and
generate cAMP signal, which may inhibit the IFN-g-induced ac-
tivation of Jak1,2/STAT1a signaling pathway, and resultantly inhi-
bit IP-10 transcription in keratinocytes. We recently found that
cAMP signal induced by prostaglandin E2 inhibited IFN-g-in-
duced STAT1a activation and IP-10 production in human epider-
moid carcinoma A431 (Kanda and Watanabe, 2002). A variety
of studies reported the cAMP-mediated inhibition of STAT1a
(David et al, 1996; Ivashkiv et al, 1996; Sengupta et al, 1996; Catalan
et al, 1997; Lee and Rikihisa, 1998; Meloche et al, 2000; Rocchi
et al, 2000). It is also reported that cAMP-elevating agents inhib-
ited IFN-g-inducible gene expression; vasoactive intestinal poly-
peptide and pituitary adenylate cyclase-activating polypeptide
inhibited IFN-g-induced STAT1 binding to IFN-g-activated site
on the promoter of IFN regulatory factor-1 via cAMP signal and
thus suppressed this gene expression in murine macrophages
(Delgado and Ganea, 2000). Multiple mechanisms have been sup-
posed for the cAMP-mediated inhibition of STAT1 activation: (i)
protein kinase A (PKA) activated by cAMP may suppress the
synthesis of STAT1 (Ivashkiv et al, 1996), or (ii) of Jak1 or Jak2
(Meloche et al, 2000); (iii) PKA may phosphorylate Jak1 or Jak2
on serine residues, which reduces their tyrosine kinase activities
(Meloche et al, 2000); and (iv) PKA may stimulate the activity of
protein tyrosine phosphatase that inactivates Jak1 or Jak2 (Catalan
et al, 1997; Lee and Rikihisa, 1998; Meloche et al, 2000; Rocchi
et al, 2000). Among these, the ¢rst and second mechanisms
are rather unlikely as the amount of Jak1, Jak2, or STAT1 was
not altered by E2. The third mechanism is supposed for another
Jak family kinase,Tyk2; however, it is reported that Jak1 and Jak2
do not contain possible a PKA recognition site (Meloche et al,
2000). The fourth mechanism is rather likely as PKA is known
to phosphorylate tyrosine phosphatases SHPTP2 and SHPTP1
on serine, which enhances their tyrosine phosphatase activity
(Bouchard et al, 1994; Catalan et al, 1997; Rocchi et al, 2000).
Further studies should elucidate if E2 may activate SHPTP1,
SHPTP2, or another protein tyrosine phosphatase, which can in-
activate Jak1 or Jak2. Another possible mechanism is that activated
PKA may serine-phosphorylate IFN-g receptor, which may pre-
vent its dimerization and the activation of Jak1/Jak2 associated
with the receptor. As PKA constitutively associates with IFN-a/
b receptors (David et al, 1996), its association with IFN-g receptor
before and after E2 incubation should also be examined in
further studies.
E2-BSA, impermeable E2 analog, which cannot interact with
classical intracellular ER, generated cAMP as well as unconju-
gated E2, indicating that the e¡ects of E2 may be exerted at
the membrane and may not be mediated via intracellular ER.
The binding of E2-BSA-FITC to keratinocytes also supported
the presence of membrane E2-binding sites on keratinocytes.
The putative membrane E2-binding sites may be structurally
di¡erent from classical nuclear ER or post-translationally
modi¢ed forms of nuclear ER according to membrane targeting
(Papas et al, 1995; Kim et al, 1999; Razandi et al, 1999). The recent
study (Razandi et al, 1999) showed that membrane and nuclear
ER arise from a single transcript, and that the stimulation of
membrane ERa and ERb by E2 both generated cAMP in
Chinese hamster ovary cells transfected with ERa or ERb
(Razandi et al, 1999). Thus the putative membrane E2-binding
sites on keratinocytes may be possibly derived from the same
transcript as that of nuclear ER. Reverse transcription^PCR
detected only ERb mRNA but not that of ERa in keratino-
cytes. Thus ERb functionally linked to AC may exist on
keratinocyte membranes, and this possibility should further
be examined.
In this and previous studies (Kanda and Watanabe, 2002) and
some of the studies in other laboratories, anti-estrogen ICI 182
780 or tamoxifen did not antagonize E2-induced cAMP increase
(Aronica et al, 1994; Razandi et al, 1999; Beyer and Karolczak,
2000). ICI 182 780, tamoxifen or other anti-estrogens rather inde-
pendently generated cAMP (Aronica et al, 1994; Farhat et al, 1996;
Figure 7. The inhibition by several signal inhibitors on E2-mediated suppression of IP-10 secretion (a), promoter activity (b), and mRNA
expression (c) induced by IFN-c. (a,c) Keratinocytes were preincubated with 200 mM SQ22536, 1 mM U73122, or 20 mM PD98059 for 10 min, then
incubated with 108 M E2 for 10 min prior to the addition of 10 ng IFN-g per ml. IP-10 secretion was analyzed after 24 h, whereas RNAwas extracted
after 3 h. In some experiments, 1 mM dibutyryl cAMP (Bt2cAMP) was added in place of E2 prior to the addition of IFN-g. (b) Keratinocytes were tran-
siently transfected with human IP-10 promoter linked to luciferase reporter plasmid, and incubated as above. After 6 h, luciferase activities of the cell lysates
were analyzed and were normalized for b-galactosidase activities. In (a) and (b), values are mean7SEM of ¢ve separate experiments. npo0.05 vs control
values, wpo0.05 vs values with IFN-g, and zpo0.05 vs values with IFN-g plus E2, by one-way ANOVAwith Sche¡e’s multiple comparison test. The results
shown in (c) are representative of ¢ve separate experiments.
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Razandi et al, 1999). Tamoxifen acts as either an antagonist or an
agonist for nuclear ER, depending on the cell types and target
gene promoter context (Berry et al, 1990). ICI 182 780 and other
ICI compounds were once thought to be pure antagonists for nu-
clear ER (Berry et al, 1990); however, it has recently been re-
ported that ICI compounds can enhance nuclear ER-mediated
transcriptional activation through activator-protein-1 elements
(Paech et al, 1997). Recent studies also report that ICI 182 780
modulates membrane ER-mediated e¡ects (Stefano et al, 1999;
Wade et al, 2001; Machado et al, 2002). Especially ICI 182 780
and tamoxifen activated ERK in ERb-transfected Rat-2 cells,
whereas antagonized E2-induced ERK activation in ERa-trans-
fected cells (Wade et al, 2001). Thus the e¡ects of ICI 182 780 or
tamoxifen appear to di¡er between ERa and ERb, and these
agents may act as agonists for membrane ERb-mediated AC
activation in keratinocytes.
It is also plausible that E2-binding sites on keratinocyte mem-
branes may be completely di¡erent from classical nuclear ERb,
and this possibility should also be investigated. E2 interacts with
sex hormone-binding globulin (SHBG) prebound to membrane
SHBG receptor, and generates cAMP signal in prostate cells or
breast cancer MCF-7 (Fissore et al, 1994; Nakla et al, 1994). As ker-
atinocytes were not preincubated with exogenous SHBG prior to
E2 incubation in this study, the involvement of SHBG receptor
in E2-induced AC activation is rather unlikely in keratinocytes;
however, it is still possible that endogenous SHBG prebound to
SHBG receptor on keratinocytes may interact with E2, and such
a possibility should further be investigated. E2 can also interact
with N-methyl-D-aspartate receptors, which are linked to AC
(Roberson and Sweatt, 1996), on rat hippocampal cell membranes
(Woolley and McEwen, 1994). As functional N-methyl-D-aspar-
tate receptors also exist in keratinocytes (Genever et al, 1999), these
may act as E2-binding sites on keratinocyte membranes.
Our present results suggest that E2 may block the positive
feedback loop of IFN-g/IP-10 occurring in psoriatic skin lesions
and attenuateT helper 1-mediated in£ammation.We also prelimi-
narily found that E2 suppressed IFN-g-induced mRNA expres-
sion of another T helper 1-attracting chemokine, Mig in human
keratinocytes (data not shown) and are now studying the precise
mechanism for this phenomenon. These results indicate that E2-
induced regulation of IP-10 or Mig production may be related to
the modi¢cation of psoriatic symptoms during pregnancy and
support that E2 may be useful for the treatment of patients with
psoriasis. IP-10, however, may not be an exclusive factor deter-
mining the course of in£ammatory skin diseases as allergic
contact dermatitis or atopic dermatitis associated with IP-10 pro-
duction (Flier et al, 1999; Giustizieri et al, 2001) rather exacerbates
during pregnancy (Vaughan Jones et al, 1999). Arnold et al (1993)
Figure 8. The e¡ects of several signal inhibitors on the suppression
by E2 on ISRE-dependent transcription (a), transcription factor
binding to ISRE (b), and STAT1a, Jak1, or Jak2 tyrosine phosphor-
ylation (c) induced by IFN-c. (a) Keratinocytes were transiently trans-
fected with luciferase reporter vector driven by ISRE linked to minimal
SV40 promoter. Cells were preincubated with 200 mM SQ22536, 1 mM
U73122, or 20 mM PD98059 for 10 min, then incubated with 108 M E2
for 10 min prior to the addition of 10 ng IFN-g per ml. After 6 h, luciferase
activities of the cell lysates were analyzed and normalized for b-galactosi-
dase activities. In some experiments, 1 mM dibutyryl cAMP (Bt2cAMP)
was added in place of E2 prior to the addition of IFN-g. The data are
mean7SEM of ¢ve separate experiments. npo0.05 vs control values with
medium alone, wpo0.05 vs values with IFN-g alone, and zpo0.05 vs values
with IFN-g plus E2, by one-way ANOVAwith Sche¡e’s multiple comparison
test. (b,c) Keratinocytes were preincubated and incubated as above. After 30
min, nuclear extracts were obtained and analyzed for EMSA using ISRE
probe (b). Cell lysates were obtained after 10 min, and immunoprecipitated
with anti-STAT1a, Jak1, or Jak2 antibodies followed by immunoblotting
with anti-phosphotyrosine antibody (c, upper panel). The blots were also
stripped and reprobed with anti-STAT1a, Jak1, or Jak2 antibodies, respec-
tively (c, lower panel). The results shown in the ¢gure are representative of
¢ve separate experiments.
Figure 9. The e¡ects of sex hormones on the intracellular cAMP
level. Keratinocytes were incubated with medium alone, E2 (108 M), E2-
BSA (107M), ICI 182 780 (106 M), tamoxifen (106 M), progesterone (108
M), or DHT (108 M), in the presence or absence of IFN-g 10 ng per ml.
The intracellular cAMP level was analyzed at the indicated time points.
The mean of triplicate cultures is shown; the SD wereo10% of the means.
The data are representative of four separate experiments.
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reported that estrogen inhibits the induction of epidermal or-
nithine decarboxylase, required for DNA replication, indicating
that estrogen may inhibit keratinocyte hyperproliferation occur-
ring in psoriasis, which may be another anti-psoriatic e¡ect of
estrogen. To date, therapeutic e¡ects of E2 on psoriasis have
hardly been studied in vivo. Only one study reported that combi-
national usage of estrogen with corticosteroid reduced the dose
of the latter drug required for a psoriatic patient, indicating the
synergistic e¡ect of estrogen (Spangler et al, 1969). Additional
insights into therapeutic e¡ects of E2 on psoriasis may be pro-
vided by prospective studies of postmenopausal patients with
hormone replacement therapy or patients taking fertility drugs
or oral contraceptives.
This work was supported in part by the grant from Japan Society for the Promotion of
Science (14570825) and an aid from Shiseido.
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